Scancell Holdings is a clinical-stage biopharmaceutical company based in the United Kingdom that develops immunotherapies for cancer. Its work centres on vaccine and antibody technologies designed to stimulate a patient's immune system to attack tumours, with programmes aimed at melanoma and other solid cancers. The company carries out laboratory and clinical research and works with partners and investigators to test its treatments in patients, while its pipeline remains at the development stage rather than being sold commercially.
On this site Scancell Hldgs Plc appears as a stock on the London Exchange (UK), code SCLP, with prices in pence sterling (GBX). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Weak price profile
Ranks #3210 of 3787 on the London Exchange · confidence High
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for UK yet.
TrendWeak
6/100
Below its long-term averages and far from its highs.
See the numbers →
Above 200-day average-32.3%
From 52-week high-65.7%
MomentumWeak
27/100
Lagging most stocks on this exchange.
See the numbers →
3-month return-13.3%
6-month return-30.0%
12-month, skipping last month1.6%
Stability (higher is calmer)Weak
15/100
Volatile, with deep drawdowns.
See the numbers →
Volatility, 1 year (lower is calmer)60.4%
Worst drawdown, 1 year (smaller is calmer)-66.0%
LiquidityStrong
80/100
Trades actively.
See the numbers →
Avg daily value traded24.68M GBX
Zero-volume days0.0%
IncomeNone
–/100
Pays no dividend.
See the numbers →
Years with dividends0
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for UK when fundamentals data for this market is added. All UK stocks.
52-wk range 90.00 – 295.00Daily closes, split-adjusted
Signals
50-day average95.75
200-day average134.32
Golden/death cross (60d)Death, 44 days ago
New 52-week highNo
Bullish RSI divergenceYes
Average daily range (ATR)2.18
Technical summary
Daily
Strongly bearish
3 bullish · 1 neutral · 12 bearish
Weekly
Strongly bearish
0 bullish · 1 neutral · 11 bearish
Monthly
Strongly bearish
0 bullish · 1 neutral · 7 bearish
Moving averages (daily)
SMA 10
92.52
Bearish
EMA 10
92.27
Bearish
SMA 20
93.39
Bearish
EMA 20
93.45
Bearish
SMA 50
95.75
Bearish
EMA 50
99.93
Bearish
SMA 100
122.0
Bearish
EMA 100
113.0
Bearish
SMA 200
134.3
Bearish
EMA 200
121.2
Bearish
Oscillators (daily)
RSI (14)
30.47
Neutral
MACD (12, 26)
-1.71
Bearish
Momentum (12)
-3.19
Bearish
Stochastic %K (14)
16.67
Bullish
Williams %R (14)
-83.33
Bullish
CCI (20)
-208.4
Bullish
Pivot points (classic, last session)
S3
88.00
S2
89.00
S1
90.00
Pivot
91.00
R1
92.00
R2
93.00
R3
94.00
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Prices are end-of-day closes in GBX. Educational only, not financial advice.
